XIFAXAN
- Product NDC
- 69189-0309
- 11-digit product format
- 691890309
- Labeler code
- 69189
- Product ID
- 69189-0309_36bc6a96-544d-4b0b-937d-323e308da080
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rifaximin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Avera McKennan Hospital
- Application
- NDA021361
- Marketing category
- NDA
- Marketing start
- 2015-05-07
- Marketing end
- 0000-00-00
- Substance
- RIFAXIMIN
- Active strength
- 200 mg/1
- Pharmacologic classes
- Rifamycin Antibacterial [EPC],Rifamycins [CS]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69189-0309-1 | XIFAXAN | 1 in 1 DOSE PACK | TABLET | 1 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69189-0309 | XIFAXAN (RIFAXIMIN) TABLET [AVERA MCKENNAN HOSPITAL] | 1 | Legacy NDC, 1 package rows | 20170414_e2991a17-fa65-49bd-a5e3-c41f2179dd9e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 69189-0309-1 | 69189030901 | 1 in 1 DOSE PACK | Historical |